11. národní očkovací den, 2005
10. národní očkovací den, 2004
pozvánka
program
9. národní očkovací den, 2003
8. národní očkovací den, 2002
7. národní očkovací den, 2001
6. národní očkovací den, 2000

zpět na úvodní stranu 10. národního očkovacího dne

Immunization in European countries

Wilhelm Sedlak, Austria nad CESP

Wellcome to EU, wellcome to CESP ( confederation of European Specialists in Paediatrics)! The explosive development of new vaccines ( eg conjugate pneumococcal or meningococcal vaccines, new influenza vaccines, varicella) or vaccine combinations and their potential availabilitiy for introduction into vaccination programms raise the question of the selection of appropriate vaccination policies in EU– countries, especially for the incoming countries; -taking into account cost-benefit assessments of new vaccination approaches as well as relative needs in different parts of Europe. Although infectious disease still represent an important overall cause of child mortality and morbidity in the European region, considerable differences exist regarding their impact in different parts of Europe. Their should be no question for routine 6–compound-vaccine ( DI, Tet, IPV, Hib, Hepatitis B, acell. Pertussis ) in the first monthes of life, MMR 2 times in the first 2 years of life, and an adequate catchup vaccination program at the first year of school (eg Di, Tet, IPV, acell.pertussis), as well as after the age of 13 years. 
Even so the World Health Organization has focused vaccination programs exclusively for children less than five years in age, there is a great demand for special vaccination –programs for adolescents and adults, eg. acellular pertussis, hepatitis B and A, pneumococcal and menigococcal, varicella, influenza, FSME in Middle and South-East European countries. 
The great efficacy and vaccination proposals (general programms in some European countries respectively) of the new conjugate menigococcal and pneumococcal vaccines will be discussed; also the question “do we have a need for a general varicella vaccination-progamme in European children” like the USA do ? 
It is very important to detect and evaluate adverse events following vaccines, separating true and false adverse reactions, so there are increased concerns of many parents about the safety of hepatitis B,Hib, MMR, DTP, Polio disease vaccines; many are based on inappropriate interpretations; addressingparents concerns: do vaccines contain harmful preservatives, adjuvants, additives or residuals ? The Austrian Vaccination-schedule 2004 will be demonstrated.